Correction: Stayble Therapeutics publishes interim report for the third quarter of 2023
Republishes with MAR text in the press release. No changes have been made to the press release or the attached report. Stayble Therapeutics AB ("Stayble" or the "Company") hereby publishes its quarterly report for the third quarter of 2023. The report is available as an attached document and on the Company's website, www.staybletherapeutics.com/en/investors/financial-reports/. Below is a summary of the report.Summary Highlights during the third quarter (July – September 2023) · In July, Stayble announced that about 90% of the patients in the ongoing Phase IIb study for